Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9J77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,899
Award facts
- Contract value 100% obligated
- $24,898.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,898.95 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on November 26, 2025, with completion targeted for November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award resulted from open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. Dupixent (dupilumab) is a biologic medication primarily used to treat atopic dermatitis, eosinophilic esophagitis, and asthma, and its inclusion in federal procurement reflects the Defense Health Agency's medical supply requirements for eligible beneficiaries. All reviewed contract awards held by AmerisourceBergen with the DLA were competitively awarded with firm fixed pricing, underscoring the company's consistent performance in meeting federal procurement standards.
Quick answers
Who was awarded contract SPE2DR26F9J77?
SPE2DR26F9J77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9J77 worth?
The government has obligated $24,899 on SPE2DR26F9J77.
Is contract SPE2DR26F9J77 an order under another contract?
Yes. SPE2DR26F9J77 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9J77 competed?
The extent of competition for SPE2DR26F9J77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award